Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cogent Biosciences (COGT) EBIT Margin: 2017-2020

Historic EBIT Margin for Cogent Biosciences (COGT) over the last 4 years, with Sep 2020 value amounting to -18,333.01%.

  • Cogent Biosciences' EBIT Margin fell 1715301.00% to -18,333.01% in Q3 2020 from the same period last year, while for Sep 2020 it was -295.79%, marking a year-over-year increase of 9838.00%. This contributed to the annual value of -1,044.33% for FY2020, which is 90131.00% down from last year.
  • As of Q3 2020, Cogent Biosciences' EBIT Margin stood at -18,333.01%, which was down 1,207.56% from -1,402.08% recorded in Q2 2020.
  • Cogent Biosciences' 5-year EBIT Margin high stood at 14.65% for Q4 2019, and its period low was -18,333.01% during Q3 2020.
  • In the last 3 years, Cogent Biosciences' EBIT Margin had a median value of -387.85% in 2019 and averaged -2,122.46%.
  • Over the last 5 years, Cogent Biosciences' EBIT Margin had its largest YoY gain of 30,051bps in 2020, and its largest YoY loss of 1,715,301bps in 2020.
  • Over the past 4 years, Cogent Biosciences' EBIT Margin (Quarterly) stood at -324.07% in 2017, then skyrocketed by 8,743bps to -236.64% in 2018, then soared by 25,129bps to 14.65% in 2019, then slumped by 1,715,301bps to -18,333.01% in 2020.
  • Its EBIT Margin stands at -18,333.01% for Q3 2020, versus -1,402.08% for Q2 2020 and -87.34% for Q1 2020.